AKSHARCHEM Q4 FY19 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 2
Fundraise
No
Order
N/A
Capex
Yes
1 of 4 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →The company expects around 15% year-on-year topline growth going forward.
- →H-Acid utilization is expected to reach 95%, adding to the topline.
- →Specialty chemicals division (precipitated silica) is expected to start within the current year, contributing to revenue.
- →Precipitated silica plant at 85% utilization is projected to generate revenues of approximately Rs.70 to 80 Crores initially.
- →Expansion focus is currently on precipitated silica, with pigment expansion planned later depending on market conditions.
- →Dye intermediates may see minor debottlenecking but no significant expansion planned now.
- →The company aims to capitalize on China's rising costs, with India's share in dye intermediate exports growing at 15-20% annually.
- →Overall, stable growth in sales and volume is anticipated driven by new product lines and better capacity utilization.
See what AKSHARCHEM management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- →The company has borrowed Rs.11.5 Crores during the year as working capital loan but remains a net cash company with a low debt-to-equity ratio of 0.04x as of March 2019.
- →Management does not expect borrowing to exceed 0.2x even after six months when all plants start.
- →No specific mention of plans for new fundraising through debt or equity during the call.
- →Expansion projects like precipitated silica and possible pigment division expansion are planned to be funded through existing cash/investments.
- →Backward integration proposals, like setting up an acid plant, are on the agenda but no funding plans disclosed yet.
- →Overall, no active or announced new fundraising through debt or equity is indicated as of the call date (May 2019).
See what AKSHARCHEM management said on order book — free account, 30 seconds.
Capex plans
Yes- →Precipitated Silica Project at Dahej: New Greenfield project with 10,000 MTPA capacity. Commercial production expected in the second half of FY2020. Total capex planned around Rs. 80 to 85 Crores, with Rs.39 Crores spent so far.
- →Capex includes infrastructure investment for future phases, so subsequent expansion phases will require less capex.
- →H-Acid Expansion: Completed with a capacity of 1,200 MTPA. Rs.38 Crores capex spent.
- →Future strategic investments may include pigment green expansion depending on market conditions, potentially post-silica project.
- →Backward integration (acid plant) is being considered but no final decision yet; plan to decide by Diwali (2019).
- →Focus currently on starting silica project; subsequent project plans to be finalized later.
Track AKSHARCHEM — get its next earnings analysis in your feed
Margin guidance
Category 2- →Topline growth expected around 15% annually due to increased capacity utilization (up to 95%) and new specialty chemicals division starting.
- →Margin improvement anticipated post stabilization of H-Acid plant, with a potential 2-3% increase in EBITDA margins.
- →EBITDA margins likely to stabilize between 10-12% given current market scenario.
- →H-Acid plant now stabilized; quality approved with exports started, potentially improving both revenues and profits.
- →Precipitated silica project to add revenue (~Rs. 70-80 Crores at 85% utilization) with EBITDA margins projected at 12-15%.
- →Pigment division to maintain EBITDA margins around 20%; possible future expansions depending on market recovery.
- →Debt levels expected to remain low with cautious working capital borrowing; company remains nearly net cash.
- →Volatility in chemical raw material prices may affect short-term profitability, but long-term outlook is positive.
Order book
How does AKSHARCHEM rank vs peers in Chemicals & Petrochemicals?
Pro featureSee full Chemicals & Petrochemicals sector rankings
How does AKSHARCHEM rank in Chemicals & Petrochemicals?
Compare AKSHARCHEM against every Chemicals & Petrochemicals company (Q4 FY19) on revenue, margins and earnings-call signals.
Continue your research
What AKSHARCHEM's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilisers & Petrochemicals Corp Ltd (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…
- SUDARSCHEM (Q1 FY27)
Volume growth has been modest (~6% in Q1), with confidence rooted in business recovery and value capture initiatives (Page 6). Key concall takeaways from…